# Corbus Pharmaceuticals Holdings, Inc.: Form 8-K, filed Aug 5, 2025

- Company: [Corbus Pharmaceuticals Holdings, Inc.](/companies/crbp.md) (CIK 1595097)
- Form: 8-K
- Filed: 2025-08-05
- Accepted by EDGAR: Aug 5, 2025, 09:00 ET
- Period: 2025-08-05
- Accession: 0000950170-25-102447
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1595097/000095017025102447/crbp-20250805.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1595097/000095017025102447/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1595097/000095017025102447/crbp-20250805.htm

Filed Aug 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-102447. Last ingested by Listed: Oct 29, 2026, 11:04 ET. No prices; not investment advice.
